Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells
1997

Link Between Protein Kinase C and Multidrug Resistance in Breast Cancer Cells

publication Evidence: moderate

Author Information

Author(s): J Budworth, TW Gant, A Gescher

Primary Institution: Medical Research Council Toxicology Unit, University of Leicester

Hypothesis

Is there a link between protein kinase C (PKC) activity and multidrug resistance (mdr) in breast carcinoma cells?

Conclusion

MCF-7/Adr cells lose MDR1 gene expression and PKC activity in a coordinated manner, suggesting a mechanistic link between them.

Supporting Evidence

  • MCF-7/Adr cells gradually regained drug sensitivity after doxorubicin was removed.
  • P-glycoprotein levels decreased significantly as drug sensitivity increased.
  • PKC isoenzyme levels reverted to those seen in wild-type cells by week 24.

Takeaway

The study shows that breast cancer cells can regain sensitivity to a drug called doxorubicin when they are no longer exposed to it, and this is linked to changes in certain proteins.

Methodology

The study measured drug sensitivity, P-glycoprotein levels, PKC isoenzyme levels, and gene copy numbers over 24 weeks after removing doxorubicin from the culture.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication